Evidence map›Paper›PMID 36414789›Full record

ArticleJournal of patient-reported outcomes2022

Patient experience of moderate asthma attacks: qualitative research in the USA and Germany.

Maggie Tabberer, Jane R Wells, Dale Chandler, Linda Abetz-Webb, Shiyuan Zhang, Wilhelmine Meeraus, Andy Fowler, David Slade

Open access · goldAbstract read
In one paragraph

Article in Journal of patient-reported outcomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Maggie TabbererGSK, Brentford, Middlesex, UK.
Jane R WellsPatient-Centered Outcomes, Adelphi Values, Bollington, Cheshire, UK.
Dale ChandlerPatient-Centered Outcomes, Adelphi Values, Bollington, Cheshire, UK.
Linda Abetz-WebbPatient-Centred Outcomes Assessments Ltd, Bollington, Cheshire, UK.
Shiyuan ZhangGSK Collegeville, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA. shiyuan.x.zhang@gsk.com.ORCID http://orcid.org/0000-0001-8523-0419
Wilhelmine MeerausGSK, Brentford, Middlesex, UK.
Andy FowlerGSK, Brentford, Middlesex, UK.
David SladeGSK, Research Triangle Park, NC, USA.
Adelphi Group (United Kingdom) · GBResearch Triangle Park Foundation · USSouth College · US

Funding

GSK 209379
6 · The paper itself

Abstract

backgroundThere is limited information available on the impact of moderate asthma exacerbations, often called "asthma attacks" (i.e., those not requiring hospitalisation or treatment with systemic corticosteroids) on patients' lives. This multi-country qualitative study explored the patient experience of these events.

methodsSemi-structured concept elicitation interviews were conducted in the USA and Germany with adult patients with asthma who had experienced a moderate asthma exacerbation in the prior 30 days. Physicians with experience in managing patients with asthma were also interviewed. Interviews explored patients' experience of symptoms and impact of moderate exacerbations and associated exacerbation triggers and treatment patterns. Physicians were also asked about their interpretation of a clinical definition and treatment of a moderate exacerbation.

resultsTwenty-eight patient (n = 20 in the USA, n = 8 in Germany) and six physician (n = 3 in the USA, n = 3 in Germany) interviews were conducted. During their moderate exacerbation, all patients reported experiencing shortness of breath, which many considered to be severe and the most bothersome symptom. Wheezing was also reported by all patients and considered severe by two thirds of patients. Most patients also reported coughing and chest tightness. All or almost all patients reported that moderate exacerbation caused fatigue/tiredness and impacted their physical functioning, emotional functioning, activities of daily living and work/school life. Most patients reported using rescue or maintenance inhalers to alleviate symptoms of the exacerbation. Conceptual saturation (i.e., the point at which no new concepts are likely to emerge with continued data collection) was achieved. Findings were used to develop a patient-focused conceptual model of the experience of moderate asthma exacerbations, outlining concepts related to triggers, symptoms, impact, and treatment from the patient perspective. Physician data was consistent with patient reports and complemented the conceptual model.

conclusionsFindings from concept elicitation interviews highlight the increased frequency, duration and severity of asthma symptoms and increased rescue medication use during moderate asthma exacerbations compared with the typical daily asthma experience, which have a substantial impact on patients' lives.

Indexed as

AsthmaConcept elicitationHealth-related quality of lifeImpactModerate asthma exacerbationSymptomsTreatment

Identifiers

PMID36414789
PMCPMC9681943
OpenAlexW4309698605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.